TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases. The company’s products include osteoarthritis treatment products, osteoporosis treatment preparations, iron preparations, antivirals preparations, urinary system treatment products, expectorants/mucolytic agents, antineoplastics agents, anti-hypertensive preparations, and anti-diabetic preparations, as well as medical devices and functional foods. It is also developing TCM-800B for the treatment of hepatitis B; PTX-9908, a polypeptide new drug for the treatment of liver cancer; TCM-606F, a botanical new drug for the treatment of nonalcoholic.